The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells

Int Immunol. 2005 Jan;17(1):73-83. doi: 10.1093/intimm/dxh188. Epub 2004 Nov 29.

Abstract

The B7/CD28 costimulatory pathway plays a critical role in T cell activation including Th1/Th2 differentiation. However, little is known about whether CD28 costimulation favors polarization of either Th1 and Th2 or both. Here, we show a critical role of the natural ligands for CD28 molecules (B7.2-Ig or B7.1-Ig fusion proteins), particularly in the induction of type 2 T cell polarization. Upon TCR-triggering with suboptimal doses of anti-CD3, costimulation of naïve CD4+ T cells with anti-CD28 mAb or B7-Ig fusion proteins led to comparable levels of IFN-gamma production. Naïve T cells could produce IL-4 when CD28 costimulation was done with B7-Ig, but not with anti-CD28. IL-4-selective upregulation was also observed when T cells from anti-OVA TCR transgenic mice were stimulated with OVA in the presence of B7-Ig. Correlating with IL-4 expression, GATA-3 expression was induced much more potently by costimulation with B7-Ig than with anti-CD28 mAb, while T-bet induction by these two costimulatory reagents was comparable. This B7 effect was also applied for naïve and antigen-primed CD8+ T cells: IL-4-expressing CD8+ T cells were generated when naïve and alloantigen-primed T cells were stimulated with anti-CD3 and recall antigens, respectively, in the presence of B7-Ig costimulation. Importantly, such CD8+ T cell differentiation required the coexistence of CD4+ T cells during the initial TCR stimulation. These observations indicate that both type 2 CD4 and CD8 T cell polarizations are efficiently induced via costimulation of CD28 with its natural ligands, although the differentiation of CD8+ T cells is dependent on CD4+ cells.

MeSH terms

  • Animals
  • Antigen Presentation / physiology
  • Antigens, CD / pharmacology
  • Antigens, CD / physiology*
  • B7-1 Antigen / pharmacology
  • B7-1 Antigen / physiology*
  • B7-2 Antigen
  • CD28 Antigens / pharmacology
  • CD28 Antigens / physiology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology*
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics
  • Female
  • GATA3 Transcription Factor
  • Gene Expression / drug effects
  • Immunoglobulin G / pharmacology
  • Immunoglobulin G / physiology
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / genetics
  • Interleukin-4 / biosynthesis*
  • Interleukin-4 / genetics
  • Ligands
  • Lymphocyte Activation / physiology
  • Membrane Glycoproteins / pharmacology
  • Membrane Glycoproteins / physiology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • RNA, Messenger / analysis
  • RNA, Messenger / metabolism
  • Receptors, Antigen, T-Cell, alpha-beta / genetics
  • Recombinant Fusion Proteins / pharmacology
  • Recombinant Fusion Proteins / physiology
  • Trans-Activators / biosynthesis
  • Trans-Activators / genetics

Substances

  • Antigens, CD
  • B7-1 Antigen
  • B7-2 Antigen
  • CD28 Antigens
  • Cd86 protein, mouse
  • DNA-Binding Proteins
  • GATA3 Transcription Factor
  • Gata3 protein, mouse
  • Immunoglobulin G
  • Ligands
  • Membrane Glycoproteins
  • RNA, Messenger
  • Receptors, Antigen, T-Cell, alpha-beta
  • Recombinant Fusion Proteins
  • Trans-Activators
  • Interleukin-4
  • Interferon-gamma